{"title":"100 免疫学和细胞生物学。","authors":"Adrian Liston","doi":"10.1111/imcb.12707","DOIUrl":null,"url":null,"abstract":"<p>It is a special honor to be penning an editorial to introduce our final issue this year, the 100th years of publication of <i>Immunology & Cell Biology</i>.</p><p>I am hardly alone among Australian and New Zealand immunologists in having a special place in my heart for <i>Immunology & Cell Biology</i>. The journal was founded 100 years ago in Adelaide as the <i>Australian Journal of Experimental Biology and Medical Science</i> but became <i>Immunology & Cell Biology</i> more recently under Ieva Kotlarski in 1987. I first studied immunology at the University of Adelaide in Ieva's last years prior to retirement, although by that time the journal had moved over to Canberra under Chris Parish's leadership. My career followed that of <i>Immunology & Cell Biology</i>, as I moved for my PhD in Chris Goodnow's lab to the John Curtain School of Medical Research, with the Parish lab just down the hallway. <i>ICB</i> was ubiquitous, with all students and staff receiving the monthly issue in their pigeonhole, making it one of the few journals that everyone flicked through the pages of. One of my very first papers found its home in <i>ICB</i>,<span><sup>1</sup></span> in a field on which I am still working today.</p><p>A special moment for me in my early career came through Chris Parish's request for me to review a paper for <i>ICB</i>. Reviewing papers with my supervisor was a common enough request, but a request direct to me, as a PhD student, felt entirely different, it was a moment where I felt that perhaps I was also a professional scientist. I will be forever grateful to Chris for being so inclusive of early career researchers, a theme which I hope to continue for the journal. I later served on the editorial board under Chris, and as Deputy Editors under Gabrielle Belz, at the pivotal point where Gabrielle created the sister journal <i>Clinical & Translational Immunology</i>.<span><sup>2</sup></span> I took a few years out from <i>ICB</i> service, in anticipation of a professional move to Cambridge, but when the opportunity arose to apply for Editor-in-Chief I thought “where better to invest my service time than in the journal that supported my early career.” I rejoined as Deputy Editor under Anne La Flamme, and observed her boundless energy, before taking up the EiC position myself earlier this year.</p><p>What magnificent timing! To be Editor-in-Chief as we enter our 100th year! I must say, I thought I knew <i>ICB</i> well, but my decades of interaction with the journal barely scratched the surface of its history. It wasn't until this year, preparing for our centenary, that I realized how profoundly <i>ICB</i> has shaped immunology, at a personal, national and international level. Early editors are mythical figures in Australian immunology – many current immunologists (including myself) were trained under the CJ Martin Fellowship, named after one of our early Editors-in-Chief, while Derrick Rowley, EiC decades later, founded the Australian Society for Immunology (precursor to today's Australian and New Zealand Society of Immunology). As for the content published in <i>ICB</i> over the decades… I may be biased, but I think few, if any, journals have so profoundly influenced the basic tenants of immunology. From the clonal selection theory under MacFarlane Burnet<span><sup>3</sup></span> to findings on pox immunization by Frank Fenner<span><sup>4</sup></span> (culminating in his leadership of Smallpox eradication), from Don Metcalf's colony-forming assay<span><sup>5</sup></span> to Ken Shortman's density gradient centrifugation,<span><sup>6</sup></span> our journal laid the foundation of immunology. <i>ICB</i>'s contributions hardly stopped there – Gus Nossal's work on germinal center formation,<span><sup>7</sup></span> Kevin Lafferty's “two signal hypothesis,”<span><sup>8</sup></span> the generation of OT-II transgenic mice,<span><sup>9</sup></span> or the invention of the CFSE method for lymphocyte proliferation<span><sup>10</sup></span> – all published first in <i>ICB</i>.</p><p>I am barely scratching the surface of <i>ICB</i>'s contribution over the past 100 years, but fortunately we have an entire issue to explore contributions. Our lead article goes through the personalities and history of this 100 years,<span><sup>11</sup></span> and I promise is a fascinating read. If you want to read more about a particular era, we have more detailed articles on the early,<span><sup>12</sup></span> middle<span><sup>13</sup></span> and modern<span><sup>14</sup></span> periods. Take a look if you want to know more about how <i>ICB</i> grew on the back of WWII submarines blockading international shipping, or how Mark Mitchell was able to convince NHMRC to fund paper supplies during rationing.</p><p>In this issue, we also take a deep dive into some of the key personalities who made the journal what it is today – including Kevin Lafferty,<span><sup>15</sup></span> Bede Morris,<span><sup>16</sup></span> Margaret Baird,<span><sup>17</sup></span> Dora Lush<span><sup>18</sup></span> and Allan William Cripps.<span><sup>19</sup></span> We also have a fascinating interview with the editorial team that makes everything happen at <i>ICB</i> – a must for anyone interested in how journals work behind-the-scenes.<span><sup>20</sup></span> Finally, we focus on just a few of the key areas where <i>ICB</i> has made history – in tumor immunology,<span><sup>21</sup></span> veterinary immunology<span><sup>22</sup></span> and clinical immunology.<span><sup>23</sup></span></p><p>I hope you enjoy reading this very special issue of <i>ICB</i> as much as we have enjoyed putting it together.</p><p>Adrian Liston is the Editor in Chief of <i>Immunology & Cell Biology.</i></p>","PeriodicalId":179,"journal":{"name":"Immunology & Cell Biology","volume":"101 10","pages":"880-881"},"PeriodicalIF":3.2000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"100 years of Immunology & Cell Biology\",\"authors\":\"Adrian Liston\",\"doi\":\"10.1111/imcb.12707\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>It is a special honor to be penning an editorial to introduce our final issue this year, the 100th years of publication of <i>Immunology & Cell Biology</i>.</p><p>I am hardly alone among Australian and New Zealand immunologists in having a special place in my heart for <i>Immunology & Cell Biology</i>. The journal was founded 100 years ago in Adelaide as the <i>Australian Journal of Experimental Biology and Medical Science</i> but became <i>Immunology & Cell Biology</i> more recently under Ieva Kotlarski in 1987. I first studied immunology at the University of Adelaide in Ieva's last years prior to retirement, although by that time the journal had moved over to Canberra under Chris Parish's leadership. My career followed that of <i>Immunology & Cell Biology</i>, as I moved for my PhD in Chris Goodnow's lab to the John Curtain School of Medical Research, with the Parish lab just down the hallway. <i>ICB</i> was ubiquitous, with all students and staff receiving the monthly issue in their pigeonhole, making it one of the few journals that everyone flicked through the pages of. One of my very first papers found its home in <i>ICB</i>,<span><sup>1</sup></span> in a field on which I am still working today.</p><p>A special moment for me in my early career came through Chris Parish's request for me to review a paper for <i>ICB</i>. Reviewing papers with my supervisor was a common enough request, but a request direct to me, as a PhD student, felt entirely different, it was a moment where I felt that perhaps I was also a professional scientist. I will be forever grateful to Chris for being so inclusive of early career researchers, a theme which I hope to continue for the journal. I later served on the editorial board under Chris, and as Deputy Editors under Gabrielle Belz, at the pivotal point where Gabrielle created the sister journal <i>Clinical & Translational Immunology</i>.<span><sup>2</sup></span> I took a few years out from <i>ICB</i> service, in anticipation of a professional move to Cambridge, but when the opportunity arose to apply for Editor-in-Chief I thought “where better to invest my service time than in the journal that supported my early career.” I rejoined as Deputy Editor under Anne La Flamme, and observed her boundless energy, before taking up the EiC position myself earlier this year.</p><p>What magnificent timing! To be Editor-in-Chief as we enter our 100th year! I must say, I thought I knew <i>ICB</i> well, but my decades of interaction with the journal barely scratched the surface of its history. It wasn't until this year, preparing for our centenary, that I realized how profoundly <i>ICB</i> has shaped immunology, at a personal, national and international level. Early editors are mythical figures in Australian immunology – many current immunologists (including myself) were trained under the CJ Martin Fellowship, named after one of our early Editors-in-Chief, while Derrick Rowley, EiC decades later, founded the Australian Society for Immunology (precursor to today's Australian and New Zealand Society of Immunology). As for the content published in <i>ICB</i> over the decades… I may be biased, but I think few, if any, journals have so profoundly influenced the basic tenants of immunology. From the clonal selection theory under MacFarlane Burnet<span><sup>3</sup></span> to findings on pox immunization by Frank Fenner<span><sup>4</sup></span> (culminating in his leadership of Smallpox eradication), from Don Metcalf's colony-forming assay<span><sup>5</sup></span> to Ken Shortman's density gradient centrifugation,<span><sup>6</sup></span> our journal laid the foundation of immunology. <i>ICB</i>'s contributions hardly stopped there – Gus Nossal's work on germinal center formation,<span><sup>7</sup></span> Kevin Lafferty's “two signal hypothesis,”<span><sup>8</sup></span> the generation of OT-II transgenic mice,<span><sup>9</sup></span> or the invention of the CFSE method for lymphocyte proliferation<span><sup>10</sup></span> – all published first in <i>ICB</i>.</p><p>I am barely scratching the surface of <i>ICB</i>'s contribution over the past 100 years, but fortunately we have an entire issue to explore contributions. Our lead article goes through the personalities and history of this 100 years,<span><sup>11</sup></span> and I promise is a fascinating read. If you want to read more about a particular era, we have more detailed articles on the early,<span><sup>12</sup></span> middle<span><sup>13</sup></span> and modern<span><sup>14</sup></span> periods. Take a look if you want to know more about how <i>ICB</i> grew on the back of WWII submarines blockading international shipping, or how Mark Mitchell was able to convince NHMRC to fund paper supplies during rationing.</p><p>In this issue, we also take a deep dive into some of the key personalities who made the journal what it is today – including Kevin Lafferty,<span><sup>15</sup></span> Bede Morris,<span><sup>16</sup></span> Margaret Baird,<span><sup>17</sup></span> Dora Lush<span><sup>18</sup></span> and Allan William Cripps.<span><sup>19</sup></span> We also have a fascinating interview with the editorial team that makes everything happen at <i>ICB</i> – a must for anyone interested in how journals work behind-the-scenes.<span><sup>20</sup></span> Finally, we focus on just a few of the key areas where <i>ICB</i> has made history – in tumor immunology,<span><sup>21</sup></span> veterinary immunology<span><sup>22</sup></span> and clinical immunology.<span><sup>23</sup></span></p><p>I hope you enjoy reading this very special issue of <i>ICB</i> as much as we have enjoyed putting it together.</p><p>Adrian Liston is the Editor in Chief of <i>Immunology & Cell Biology.</i></p>\",\"PeriodicalId\":179,\"journal\":{\"name\":\"Immunology & Cell Biology\",\"volume\":\"101 10\",\"pages\":\"880-881\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2023-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immunology & Cell Biology\",\"FirstCategoryId\":\"2\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/imcb.12707\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CELL BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunology & Cell Biology","FirstCategoryId":"2","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/imcb.12707","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
我特别荣幸地为我们今年的最后一期——《免疫学》出版100周年——写一篇社论。细胞生物学。在澳大利亚和新西兰的免疫学家中,免疫学在我心中占有特殊地位的并不只是我一个人。细胞生物学。该杂志100年前在阿德莱德创刊,当时名为《澳大利亚实验生物学和医学科学杂志》,后来更名为《免疫学》。细胞生物学最近在1987年由Ieva Kotlarski教授。在Ieva退休前的最后几年,我在阿德莱德大学(University of Adelaide)学习了免疫学,尽管那时杂志已经搬到了堪培拉,由克里斯·帕里什(Chris Parish)领导。我的职业生涯紧随免疫学之后。细胞生物学,因为我从克里斯·古德诺的实验室搬到约翰·柯德医学院攻读博士学位,教区实验室就在走廊那头。ICB无处不在,所有的学生和教职员工都会在他们的文件夹里收到月刊,这使它成为少数几个人人都会翻阅的期刊之一。我最早的一篇论文是在ICB中找到的,我今天仍在研究这个领域。在我早期的职业生涯中,克里斯·帕里什(Chris Parish)邀请我为ICB审阅一篇论文,这对我来说是一个特殊的时刻。和我的导师一起审阅论文是很常见的要求,但作为一名博士生,直接向我提出的要求感觉完全不同,在那个时刻,我觉得自己也许也是一名专业科学家。我将永远感激克里斯对早期职业研究人员的包容,我希望这一主题能在杂志上继续下去。后来,我在克里斯手下担任编辑委员会成员,并在加布里埃尔·贝尔兹手下担任副编辑,在加布里埃尔创办姊妹期刊《临床》的关键时刻;翻译免疫学2我离开ICB工作了几年,期待着成为剑桥大学的专业人士,但当有机会申请总编辑时,我想“有什么比在支持我早期职业生涯的期刊上投入我的服务时间更好的地方呢?”在今年早些时候我开始担任EiC的职位之前,我重新加入了安妮·拉·弗莱姆(Anne La Flamme)的副主编,并观察到了她无限的活力。多好的时机啊!在我们进入100周年之际担任总编辑!我必须说,我以为我很了解ICB,但我与该杂志几十年的互动仅仅触及了它历史的表面。直到今年,在筹备我们的百年纪念时,我才意识到ICB在个人、国家和国际层面上对免疫学产生了多么深远的影响。早期的编辑是澳大利亚免疫学的神话人物-许多现在的免疫学家(包括我自己)都是在CJ马丁奖学金下接受培训的,该奖学金以我们早期的主编之一命名,而德里克罗利,EiC几十年后,创立了澳大利亚免疫学学会(今天的澳大利亚和新西兰免疫学学会的前身)。至于几十年来在ICB上发表的内容……我可能有偏见,但我认为很少有期刊(如果有的话)对免疫学的基本租户产生如此深刻的影响。从麦克法兰·伯内特(MacFarlane burnett)的克隆选择理论,到弗兰克·芬纳(Frank Fenner4)关于痘免疫的发现(最终以他领导的根除天花运动而告终),从唐·梅特卡夫(Don Metcalf)的菌落形成试验,到肯·肖尔曼(Ken Shortman)的密度梯度离心法,我们的杂志奠定了免疫学的基础。ICB的贡献还不止于此——格斯·诺萨尔关于生发中心形成的研究,凯文·拉弗蒂的“两信号假说”,OT-II转基因小鼠的产生,以及用于淋巴细胞增殖的CFSE方法的发明——都首先发表在ICB上。我对国际清算银行过去100年的贡献只做了皮毛,但幸运的是,我们有一个完整的问题来探讨贡献。我们的头条文章回顾了这100年来的人物和历史,我保证这篇文章读起来会很吸引人。如果你想了解更多关于某个特定时代的信息,我们有关于早期、中期和现代的更详细的文章。如果你想了解更多关于ICB是如何在二战潜艇封锁国际航运的背景下发展起来的,或者马克·米切尔是如何说服NHMRC在定量配给期间资助纸张供应的,看看吧。在这一期中,我们还深入探讨了一些使该杂志发展到今天的关键人物——包括凯文·拉弗蒂、比德·莫里斯、玛格丽特·贝尔德、多拉·卢什和艾伦·威廉·克里普斯。我们还对编辑团队进行了一次精彩的采访,他们使ICB的一切都发生了——对于任何对期刊幕后运作感兴趣的人来说,这是必须的最后,我们将重点关注ICB取得历史成就的几个关键领域——肿瘤免疫学、兽医免疫学和临床免疫学。我希望你们喜欢读这一期《国际商业银行》,就像我们喜欢制作它一样。 Adrian Liston是《免疫学》杂志的主编。细胞生物学。
It is a special honor to be penning an editorial to introduce our final issue this year, the 100th years of publication of Immunology & Cell Biology.
I am hardly alone among Australian and New Zealand immunologists in having a special place in my heart for Immunology & Cell Biology. The journal was founded 100 years ago in Adelaide as the Australian Journal of Experimental Biology and Medical Science but became Immunology & Cell Biology more recently under Ieva Kotlarski in 1987. I first studied immunology at the University of Adelaide in Ieva's last years prior to retirement, although by that time the journal had moved over to Canberra under Chris Parish's leadership. My career followed that of Immunology & Cell Biology, as I moved for my PhD in Chris Goodnow's lab to the John Curtain School of Medical Research, with the Parish lab just down the hallway. ICB was ubiquitous, with all students and staff receiving the monthly issue in their pigeonhole, making it one of the few journals that everyone flicked through the pages of. One of my very first papers found its home in ICB,1 in a field on which I am still working today.
A special moment for me in my early career came through Chris Parish's request for me to review a paper for ICB. Reviewing papers with my supervisor was a common enough request, but a request direct to me, as a PhD student, felt entirely different, it was a moment where I felt that perhaps I was also a professional scientist. I will be forever grateful to Chris for being so inclusive of early career researchers, a theme which I hope to continue for the journal. I later served on the editorial board under Chris, and as Deputy Editors under Gabrielle Belz, at the pivotal point where Gabrielle created the sister journal Clinical & Translational Immunology.2 I took a few years out from ICB service, in anticipation of a professional move to Cambridge, but when the opportunity arose to apply for Editor-in-Chief I thought “where better to invest my service time than in the journal that supported my early career.” I rejoined as Deputy Editor under Anne La Flamme, and observed her boundless energy, before taking up the EiC position myself earlier this year.
What magnificent timing! To be Editor-in-Chief as we enter our 100th year! I must say, I thought I knew ICB well, but my decades of interaction with the journal barely scratched the surface of its history. It wasn't until this year, preparing for our centenary, that I realized how profoundly ICB has shaped immunology, at a personal, national and international level. Early editors are mythical figures in Australian immunology – many current immunologists (including myself) were trained under the CJ Martin Fellowship, named after one of our early Editors-in-Chief, while Derrick Rowley, EiC decades later, founded the Australian Society for Immunology (precursor to today's Australian and New Zealand Society of Immunology). As for the content published in ICB over the decades… I may be biased, but I think few, if any, journals have so profoundly influenced the basic tenants of immunology. From the clonal selection theory under MacFarlane Burnet3 to findings on pox immunization by Frank Fenner4 (culminating in his leadership of Smallpox eradication), from Don Metcalf's colony-forming assay5 to Ken Shortman's density gradient centrifugation,6 our journal laid the foundation of immunology. ICB's contributions hardly stopped there – Gus Nossal's work on germinal center formation,7 Kevin Lafferty's “two signal hypothesis,”8 the generation of OT-II transgenic mice,9 or the invention of the CFSE method for lymphocyte proliferation10 – all published first in ICB.
I am barely scratching the surface of ICB's contribution over the past 100 years, but fortunately we have an entire issue to explore contributions. Our lead article goes through the personalities and history of this 100 years,11 and I promise is a fascinating read. If you want to read more about a particular era, we have more detailed articles on the early,12 middle13 and modern14 periods. Take a look if you want to know more about how ICB grew on the back of WWII submarines blockading international shipping, or how Mark Mitchell was able to convince NHMRC to fund paper supplies during rationing.
In this issue, we also take a deep dive into some of the key personalities who made the journal what it is today – including Kevin Lafferty,15 Bede Morris,16 Margaret Baird,17 Dora Lush18 and Allan William Cripps.19 We also have a fascinating interview with the editorial team that makes everything happen at ICB – a must for anyone interested in how journals work behind-the-scenes.20 Finally, we focus on just a few of the key areas where ICB has made history – in tumor immunology,21 veterinary immunology22 and clinical immunology.23
I hope you enjoy reading this very special issue of ICB as much as we have enjoyed putting it together.
Adrian Liston is the Editor in Chief of Immunology & Cell Biology.
期刊介绍:
The Australasian Society for Immunology Incorporated (ASI) was created by the amalgamation in 1991 of the Australian Society for Immunology, formed in 1970, and the New Zealand Society for Immunology, formed in 1975. The aim of the Society is to encourage and support the discipline of immunology in the Australasian region. It is a broadly based Society, embracing clinical and experimental, cellular and molecular immunology in humans and animals. The Society provides a network for the exchange of information and for collaboration within Australia, New Zealand and overseas. ASI members have been prominent in advancing biological and medical research worldwide. We seek to encourage the study of immunology in Australia and New Zealand and are active in introducing young scientists to the discipline.